Frequently asked questions.
General questions about the assessment, the science, and compliance — plus questions specific to each market DANA serves. Jump to the section that matches your use case, or schedule a demo if you don't see your question answered.
Common questions.
No. DANA is one of many tools that help a qualified professional assess a patient, and it also functions as a general wellness tool — but it is not a diagnostic tool. Results should be interpreted only by qualified professionals.
The Brain Vital cognitive assessment takes as little as about 5 minutes. It can be self-administered or clinician-administered, in-clinic or remotely.
Yes. DANA is offline-first: results are captured locally on the device and then synced encrypted to the DANA cloud once connectivity is available.
It's a composite metric combining reaction time (speed) and percent correct (accuracy) into a single, trackable score that you can follow over time against an individual's baseline.
Native iOS and Android apps (near feature-parity), plus an Angular-based web portal. Currently available in English and Spanish, with additional languages available upon request.
Yes. Native iOS & Android SDKs and a Web SDK let partners run DANA assessments inside their own products, with white-label theming, partner keys, and usage-based licensing.
DANA is HIPAA, 21 CFR Part 11, and SOC 2 Type II compliant, encrypts data in transit and at rest, and a Business Associate Agreement (BAA) is offered.
Licensing is usage-based; please schedule a demo and our team will walk through options for your organization.
Questions about the science.
Objective reaction time (speed) and percent correct (accuracy) across a battery of established cognitive tests, combined into Cognitive Efficiency Scores and a composite DANA Brain Vital Cognitive Score.
DANA uses public-domain cognitive paradigms with a strong existing scientific literature, administered in standardized, validated default batteries. Reconfiguring away from those defaults can reduce result integrity. See the full list of peer-reviewed studies for citations.
People vary widely, so a single score against population norms can be hard to interpret. DANA is designed for repeated administration so clinicians can evaluate meaningful change from a person's own baseline over time.
No. DANA is one of many tools that help a qualified professional assess a person, and it also functions as a general wellness tool — but it is not a diagnostic tool. Results should be interpreted only by qualified professionals.
Defense program questions.
DANA was originally developed for U.S. military use and offers continuity with the legacy computerized neurocognitive testing tools long used across the military — comparable subtests and the same core performance metrics (reaction time and accuracy) — while adding mobile, self-administered, offline-first delivery and a cloud portal.
Yes. Assessments are captured locally on the device and sync encrypted to the cloud when connectivity is available — built for field, shipboard, and austere operational settings.
DANA is FDA-cleared, with HIPAA, 21 CFR Part 11, and SOC 2 Type II compliance, encryption in transit and at rest, and role-based access separation.
DANA supports deployment through program sponsors, prime contractors, and direct engagement with AnthroTronix. Contact the team to discuss program requirements, contracting, and integration.
Behavioral health questions.
Yes. Assessments can be self-administered remotely on iOS or Android — a natural fit for telepsychiatry. Results are captured offline if needed and sync encrypted to the web portal.
No. DANA is not a diagnostic tool. It provides objective measurements of reaction time (speed and accuracy) that help a qualified professional in their assessment of a patient. Results should be interpreted only by qualified professionals.
Establish a baseline before the course begins, repeat the 5-minute assessment at clinically meaningful milestones during treatment, and document change against the patient's own baseline with exportable PDF summaries and CSV data.
No — it consolidates them. DANA delivers and auto-scores the standardized questionnaires you already use, and pairs them with objective cognitive performance in one longitudinal record.
Pain management questions.
Establish a cognitive baseline before the trial or implant, reassess after the intervention and at follow-ups, and document objective change against the patient's own baseline — alongside pain and functional measures.
No — it complements them. DANA delivers and auto-scores standardized questionnaires including PEG-3, PHQ-9/8, GAD-7, ISI, and PSQI, and pairs them with objective cognitive performance in one record.
About 5 minutes. It can be self-administered or staff-administered, in-clinic or remotely — so it fits pre-op workflows and post-procedure follow-ups.
No. DANA is not a diagnostic tool. It provides objective measurements that help a qualified professional in their assessment of a patient, and results should be interpreted only by qualified professionals.
Concussion & TBI questions.
Yes. DANA supports normative-data upload (CSV) so programs can view results in the context of reference populations, alongside each individual's own baseline.
Yes. DANA generates single and batch concussion (CPH) PDF reports and multi-subject screening lists — built for concussion programs and institutional workflows.
No. DANA is not a diagnostic tool. It provides objective measurements of reaction time and accuracy that help qualified professionals assess an individual and support return-to-activity discussions. Results should be interpreted only by qualified professionals.
The Brain Vital battery takes about 5 minutes on an iOS or Android device, works offline, and syncs encrypted once connectivity is available.
Cognitive impairment questions.
No. DANA is not a diagnostic tool. It provides objective measurements of reaction time and accuracy that help qualified professionals assess cognitive performance over time. Results should be interpreted only by qualified professionals as part of a fuller evaluation.
A single score is hard to interpret because people differ widely. Establishing an individual baseline and re-measuring over time lets clinicians see within-person change — the signal that matters when following memory concerns or monitoring treatment.
The AWV includes a cognitive-assessment requirement but does not mandate a specific instrument. DANA offers a fast, standardized, repeatable assessment that can support that requirement and create a baseline to track at future visits. Coding and coverage should be verified with current payer policy.
The new anti-amyloid therapies are indicated for the MCI-to-mild-dementia window and involve baseline and ongoing monitoring. DANA can provide objective, repeatable cognitive measurement to support that longitudinal follow-up — it is not a substitute for any required medical monitoring.
Yes. The assessment is about 5 minutes, can be self- or staff-administered, and works in-clinic or at home. It's designed to be low-burden and repeatable for routine follow-up.
Sleep medicine questions.
No. DANA is not a diagnostic tool. It provides objective reaction-time and accuracy data that helps a qualified sleep medicine professional assess the cognitive impact of a sleep disorder or its treatment.
ISI and PSQI capture self-reported sleep quality and insomnia severity. DANA adds an objective performance measure alongside them, so a sleep-quality complaint can be paired with quantified reaction-time and accuracy data.
Yes. Baseline before starting CPAP, CBT-I, or another treatment, then reassess at follow-up visits to show objective change against the patient's own starting point.
About 5 minutes. It can be self-administered or staff-administered, in-clinic or remotely.
Neurology & broader-care questions.
Neurology, primary care, rehabilitation medicine, senior care & aging programs, and occupational health — anywhere a patient's cognitive trajectory needs to be measured over time rather than assessed once.
Cognitive Impairment focuses specifically on serial measurement for memory concerns. This page covers the broader set of neurology and general-care settings where objective cognitive tracking is useful but the presenting concern isn't specifically memory loss.
No. DANA is not a diagnostic tool. It's a fast, repeatable objective measure that complements a full neuropsychological evaluation, primary-care visit, or rehabilitation program — not a replacement for one.
Yes. Role-aware workflow separates administration (subject, examiner) from interpretation (clinician), and the web portal aggregates results across patients for a practice, clinic, or program.
Sports medicine questions.
Yes. Each baseline takes about 5 minutes on an iOS or Android device, and multi-subject screening lists in the web portal keep team-scale administration organized. Batch PDF reports cover the whole roster.
Yes. DANA is offline-first — assessments are captured locally at the field, gym, or rink, then sync encrypted to the cloud once connectivity is available.
No. DANA is not a diagnostic tool and does not make clearance decisions. It provides objective speed-and-accuracy data against each athlete's own baseline to inform return-to-play discussions led by qualified professionals.
Symptom checklists rely on athlete self-report. DANA objectively measures reaction time and accuracy, producing a quantified trajectory from baseline through recovery that complements symptom-based tools.
Esports questions.
No. Aim trainers build mechanical skill through practice. DANA measures the cognition behind performance — reaction time, decision speed, and accuracy — and tracks it over time against each player's own baseline. It complements training tools rather than replacing them.
About 5 minutes on a standard iOS or Android device. It works offline and syncs encrypted afterward, so it fits between scrims, at a bootcamp, or remotely — no specialized hardware required.
No. DANA is not a diagnostic tool. It provides objective cognitive measurements and delivers standardized, auto-scored wellness questionnaires (ISI, PSQI, PHQ-9, GAD-7 and more) to support player-wellness and duty-of-care programs. Results should be interpreted by qualified professionals.
Yes. Native iOS & Android SDKs and a Web SDK let organizations embed DANA assessments in their own products, with white-label theming, partner keys, and usage-based licensing.
DANA is designed as a performance and wellness tool, not a gatekeeping instrument. It's best used to help players and staff understand and protect cognitive readiness — not as a sole basis for selection or dismissal decisions.
Performance optimization questions.
Sports medicine centers on injury and recovery — baselining before an injury and tracking return-to-play after one. Performance optimization is proactive: trending cognitive readiness week over week against training load, sleep, and fatigue, independent of any injury.
Performance staff and coaches working with athletes, as well as human-performance and executive-wellness programs tracking cognitive readiness in high-demand roles — anywhere fatigue and training load affect decision-making.
Yes. Each assessment takes about 5 minutes and runs on a phone or tablet the individual already has, so it fits alongside existing load-monitoring and wellness check-ins without adding meaningful time.
No. DANA is not a diagnostic tool and does not make decisions on its own. It gives coaches and performance staff an objective readiness signal to weigh alongside the other inputs they already use.
Research questions.
DANA exports raw CSV with trial-level data — per-trial reaction times and accuracy — plus structured result payloads with offline-safe record IDs, alongside PDF summaries.
Yes. Researchers can build custom batteries, choose individual tests, and configure trial counts, timing, inter-trial intervals, and per-subject options. The scientifically validated default batteries are recommended where result integrity matters most.
Yes. DANA supports longitudinal protocols measured against individual baselines, and normative datasets can be uploaded for reference comparisons.
Yes. DANA is offline-first on iOS and Android — data is captured locally with no connectivity and syncs encrypted once a connection is available, which suits distributed study sites.
Yes. Records can be tied to offline-safe, de-identified subject IDs rather than personal information, so studies can meet IRB protocols that require de-identified data.
Partner & integration questions.
Native iOS (DANA_API) and Android (dana-android) SDKs plus a Web SDK — with white-label theming, partner keys, origin allow-listing, and usage metering.
Licensing is usage-based with partner keys and metering. Contact the partnerships team to discuss terms for your product.
Yes. Partner keys, origin allow-listing, and white-label theming let DANA's assessment engine appear as a native part of your platform rather than a separate branded product.
Health platforms, EHR and telehealth vendors, wearable and wellness apps, and other software products that want validated cognitive assessment as a feature rather than building it themselves.
DANA is reimbursed by commercial and federal payers when used for a medically necessary indication — the same reimbursement basis applies whether DANA is used directly or embedded in your product via SDK. Talk to our partnerships team for current codes and guidance specific to your use case.
Talk to our team.
We can walk through your specific use case, workflow, and compliance requirements.
Schedule a Demo